Open AccessBortezomib-based regimens improve the prognosis of newly diagnosed MM patients with chromosomal aberrations except for del(17q13)
Author(s) -
Zhigang Liu,
Qiang Zeng,
Bing Xiang
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000025834
Subject(s) - bortezomib , medicine , multiple myeloma , oncology , hazard ratio , proportional hazards model , fluorescence in situ hybridization , survival analysis , multivariate analysis , confidence interval , gene , biology , chromosome , biochemistry